Primary myelofibrosis and the "bad seeds in bad soil" concept

Fibrogenesis and Tissue Repair

Volumn 5, Issue SUPPL.1, 2012, Pages

  Le Bousse Kerdilès, Marie Caroline ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; JANUS KINASE 2;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DEREGULATION; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MICROENVIRONMENT; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; OSTEOSCLEROSIS; STEM CELL MOBILIZATION; STEM CELL NICHE; STROMA CELL;

EID: 84875245207     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-5-S1-S20     Document Type: Article

References (38)

1. Tefferi A. The history of myeloproliferative disorders: before and after Dameshek. Leukemia 2008, 22:3-13. 10.1038/sj.leu.2404946, 17882283.
2. Tefferi A, Vainchenker W. Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies. J Clin Oncol 2011, 29:573-582. 10.1200/JCO.2010.29.8711, 21220604.
3. James C, Ugo V, Le Couédic JP, Staerk J, Delhommeau F, Lacout C, Garçon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005, 28:1144-1148.
4. Tefferi A. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010, 24:1128-1138. 10.1038/leu.2010.69, 3035972, 20428194.
5. Le Bousse-Kerdilès MC, Martyré MC. Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia. Springer Semin Immunopathol 1999, 21:491-508.
6. Walkley CR, Olsen GH, Dworkin S, Fabb SA, Swann J, McArthur GA, Westmoreland SV, Chambon P, Scadden DT, Purton LE. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 2007, 129:1097-1110. 10.1016/j.cell.2007.05.014, 1974882, 17574023.
7. Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 2007, 129:1081-1095. 10.1016/j.cell.2007.03.055, 2768301, 17574022.
8. Lataillade JJ, Pierre-Louis O, Hasselbalch HC, Uzan G, Jasmin C, Martyré MC, Le Bousse-Kerdilès MC, French INSERM and the European EUMNET Networks on Myelofibrosis Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence. Blood 2008, 15:3026-3035. French INSERM and the European EUMNET Networks on Myelofibrosis.
9. Perry JM, Li L. Disrupting the stem cell niche: good seeds in bad soil. Cell 2007, 129:1045-1047. 10.1016/j.cell.2007.05.053, 17574018.
10. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature 2001, 414:98-104. 10.1038/35102160, 11689954.
11. Oh IH, Kwon KR. Concise review: multiple niches for hematopoietic stem cell regulations. Stem Cells 2010, 28:1243-1249.
12. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4:7-25.
13. Morrison SJ, Spradling AC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008, 132:598-611. 10.1016/j.cell.2008.01.038, 18295578.
14. Raaijmakers MH, Scadden DT. Evolving concepts on the microenvironmental niche for hematopoietic stem cells. Curr Opin Hematol 2008, 15:301-306. 10.1097/MOH.0b013e328303e14c, 18536566.
15. Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-34. 10.1038/nature09262, 3146551, 20703299.
16. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846. 10.1038/nature02040, 14574413.
17. Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, Frenette PS. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006, 27:407-421.
18. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008, 452:442-447. 10.1038/nature06685, 18256599.
19. Hooper AT, Butler JM, Nolan DJ, Kranz A, Iida K, Kobayashi M, Kopp HG, Shido K, Petit I, Yanger K, James D, Witte L, Zhu Z, Wu Y, Pytowski B, Rosenwaks Z, Mittal V, Sato TN, Rafii S. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 2009, 4:263-274. 10.1016/j.stem.2009.01.006, 3228275, 19265665.
20. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121. 10.1016/j.cell.2005.05.026, 15989959.
21. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834. 10.1038/nature09262, 3146551, 20703299.
22. Kobayashi H, Butler JM, O'Donnell R, Kobayashi M, Ding BS, Bonner B, Chiu VK, Nolan DJ, Shido K, Benjamin L, Rafii S. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat Cell Bio 2010, 12:1046-1056.
23. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008, 8:290-301. 10.1038/nri2279, 18323850.
24. DiMascio L, Voermans C, Uqoezwa Mn Duncan A, Lu D, Wu J, Sankar U, Reya T. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol 2007, 178:3511-3520.
25. Martyré MC, Le Bousse-Kerdilès MC, members of the French INSERM Research Network on Myelofibrosis With Myeloid Metaplasia Stem cell dysregulation in myelofibrosis with myeloid metaplasia: current data on growth factor and transcription factor involvement. Semin Oncol 2005, 32:373-379. 10.1053/j.seminoncol.2005.04.009, 16202683, members of the French INSERM Research Network on Myelofibrosis With Myeloid Metaplasia.
26. Komura E, Chagraoui H, Mansat de Mas V, Blanchet B, de Sepulveda P, Larbret F, Larghero J, Tulliez M, Debili N, Vainchenker W, Giraudier S. Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression. Exp Hematol 2003, 31:622-630. 10.1016/S0301-472X(03)00085-7, 12842707.
27. Desterke C, Bilhou-Nabéra C, Guerton B, Martinaud C, Tonetti C, Clay D, Guglielmelli P, Vannucchi A, Bordessoule D, Hasselbalch H, Dupriez B, Benzoubir N, Bourgeade MF, Pierre-Louis O, Lazar V, Vainchenker W, Bennaceur-Griscelli A, Gisslinger H, Giraudier S, Le Bousse-Kerdilès MC, French Intergroup of Myeloproliferative Disorders; French INSERM and European EUMNET Networks on Myelofibrosis FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis. Cancer Res 2011, 71(8):2901-15. 10.1158/0008-5472.CAN-10-1731, 21487043, French Intergroup of Myeloproliferative Disorders; French INSERM and European EUMNET Networks on Myelofibrosis.
28. Komura E, Tonetti C, Penard-Lacronique V, Chagraoui H, Lacout C, Lecouédic JP, Rameau P, Debili N, Vainchenker W, Giraudier S. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression. Cancer Res 2005, 65:3281-3289.
29. Emadi S, Clay D, Desterke C, Guerton B, Maquarre E, Charpentier A, Jasmin C, Le Bousse-Kerdilès MC, French INSERM Research Network on MMM IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis. Blood 2005, 105:464-473. 10.1182/blood-2003-12-4415, 15454487, French INSERM Research Network on MMM.
30. Le Bousse-Kerdilès MC, Martyré MC, Samson M. Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review. Eur Cytokine Netw 2008, 19:69-80.
31. Ciurea SO, Merchant D, Mahmud N, Ishii T, Zhao Y, Hu W, Bruno E, Barosi G, Xu M, Hoffman R. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood 2007, 110:986-993. 10.1182/blood-2006-12-064626, 1924766, 17473062.
32. Le Bousse-Kerdilès MC, Martyré MC. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Ann Hematol 1999, 78:437-444. 10.1007/s002770050595, 10550553.
33. Chagraoui H, Tulliez M, Smayra T Komura E, Giraudier S, Yun T, Lassau N, Vainchenker W, Wendling F. Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. Blood 2003, 101:2983-2989. 10.1182/blood-2002-09-2839, 12506018.
34. Guglielmelli P, Zini R, Bogani C, Salati S, Pancrazzi A, Bianchi E, Mannelli F, Ferrari S, Le Bousse-Kerdilès MC, Bosi A, Barosi G, Migliaccio AR, Manfredini R, Vannucchi AM. Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). Stem Cells 2007, 25:165-173. 10.1634/stemcells.2006-0351, 16990584.
35. Bogani C, Ponziani V, Guglielmelli P, Desterke C, Rosti V, Bosi A, Le Bousse-Kerdilès MC, Barosi G, Vannucchi AM. Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis. Stem Cells 2008, 26:1920-1930. 10.1634/stemcells.2008-0377, 18511598.
36. Xu M, Bruno E, Chao J, Huang S, Finazzi G, Fruchtman SM, Popat U, Prchal JT, Barosi G, Hoffman R. Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood 2005, 105:4508-4515. 10.1182/blood-2004-08-3238, 15705794.
37. Piaggio G, Rosti V, Corselli M, Bertolotti F, Bergamaschi G, Pozzi S, Imperiale D, Chiavarina B, Bonetti E, Novara F, Sessarego M, Villani L, Garuti A, Massa M, Ghio R, Campanelli R, Bacigalupo A, Pecci A, Viarengo G, Zuffardi O, Frassoni F, Barosi G. Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker. Blood 2009, 1:3127-3130.
38. Teofili L, Martini M, Iachininoto MG, Capodimonti S, Nuzzolo ER, Torti L, Cenci T, Larocca LM, Leone G. Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms. Blood 2011, 117(9):2700-7. 10.1182/blood-2010-07-297598, 21212285.